» Articles » PMID: 7356173

Organization of Brainstem Noradrenaline Hyperinnervation Following Neonatal 6-hydroxydopamine Treatment in Rat

Overview
Date 1980 Jan 1
PMID 7356173
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neurons.

Ricaurte G, McCann U Neurotox Res. 2004; 3(1):85-99.

PMID: 15111263 DOI: 10.1007/BF03033232.


Mutant mouse tottering: selective increase of locus ceruleus axons in a defined single-locus mutation.

Levitt P, Noebels J Proc Natl Acad Sci U S A. 1981; 78(7):4630-4.

PMID: 6945603 PMC: 319847. DOI: 10.1073/pnas.78.7.4630.

References
1.
Sachs C, Pycock C, Jonsson G . Altered development of central noradrenaline neurons during ontogeny by 6-hydroxydopamine. Med Biol. 1974; 52(1):55-65. View

2.
Loren I, Bjorklund A, Falck B, Lindvall O . [An improved histofluorescence procedure for freeze-dried paraffin-embedded tissue based on combined formaldehyde-glyoxylic acid perfusion with high magnesium content and acid pH]. Histochemistry. 1976; 49(3):177-92. DOI: 10.1007/BF00492374. View

3.
Versteeg D, van Ree J, Provoost A, de Jong W . Neonatal 6-hydroxydopamine treatment: noradrenaline levels and in vitro 3H-catecholamine synthesis in discrete brain regions of adult rats. Life Sci. 1974; 15(12):2127-34. DOI: 10.1016/0024-3205(74)90029-0. View

4.
Schmidt R, Bhatnagar R . Regional development of norepinephrine, dopamine-beta-hydroxylase and tyrosine hydroxylase in the rat brain subsequent to neonatal treatment with subcutaneous 6-hydroxydopamine. Brain Res. 1979; 166(2):293-308. DOI: 10.1016/0006-8993(79)90215-4. View

5.
Oke A, Keller R, Adams R . Dopamine and norepinephrine enhancement in discrete rat brain regions following neonatal 6-hydroxydopamine treatment. Brain Res. 1978; 148(1):245-50. DOI: 10.1016/0006-8993(78)90398-0. View